|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.000 EUR | 0.00% |
|
-3.47% | -26.90% |
| Mar. 25 | Hyloris Pharmaceuticals SA Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Jan. 20 | Hyloris Pharmaceuticals Partners With Orion to Commercialize Gastric Acid Treatment | MT |
| Capitalization | 140M 162M 129M 121M 225M 15.45B 229M 1.52B 593M 7.45B 606M 593M 25.88B | P/E ratio 2026 * |
-23.1x | P/E ratio 2027 * | 9.8x |
|---|---|---|---|---|---|
| Enterprise value | 137M 158M 126M 118M 220M 15.09B 224M 1.49B 579M 7.27B 592M 579M 25.27B | EV / Sales 2026 * |
5.74x | EV / Sales 2027 * | 1.57x |
| Free-Float |
41.86% | Yield 2026 * |
40% | Yield 2027 * | 60% |
| 1 week | -3.47% | ||
| Current month | -0.40% | ||
| 1 month | -3.10% | ||
| 3 months | -20.89% | ||
| 6 months | -15.82% | ||
| Current year | -26.90% |
| 1 week | 5 |  | 5.16 |
| 1 month | 4.7 | | 5.52 |
| Current year | 4.51 | | 8.4 |
| 1 year | 4.51 | | 8.4 |
| 3 years | 2.89 | | 14.1 |
| 5 years | 2.89 | | 19.1 |
| 10 years | 2.89 | | 19.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Jacobsen
CEO | Chief Executive Officer | 52 | 2024-07-07 |
Stijn van Rompay
CEO | Chief Executive Officer | 50 | 2011-12-31 |
| Director of Finance/CFO | - | 2024-12-08 |
| Director | Title | Age | Since |
|---|---|---|---|
Stijn van Rompay
BRD | Director/Board Member | 50 | 2020-11-29 |
Thomas Jacobsen
BRD | Director/Board Member | 52 | 2011-12-31 |
Stefan Yee
CHM | Chairman | 64 | 2019-09-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| Nov. 26 | Don | Founder | 425 | 0.0015% | ||
| Nov. 26 | Don | Founder | 425 | 0.0015% | ||
| 23-06-18 | Buy | Chief Operating Officer | 12,500 | 0.0446% |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -3.47% | -18.30% | -57.08% | 162M | |
| +1.57% | +6.19% | +49.26% | +157.85% | 1,009B | |
| -0.26% | +3.87% | +49.75% | +44.86% | 560B | |
| -1.83% | +4.76% | +17.51% | +62.07% | 401B | |
| +0.77% | +3.06% | +21.96% | +15.20% | 328B | |
| -1.05% | +3.78% | +51.35% | +8.34% | 298B | |
| -0.45% | +2.69% | +27.95% | +17.41% | 288B | |
| -0.54% | +3.02% | +20.87% | +29.84% | 272B | |
| -4.17% | -4.53% | -44.53% | -50.50% | 194B | |
| -1.10% | +5.04% | +19.08% | +56.61% | 189B | |
| Average | -0.71% | +2.27% | +19.49% | +28.46% | 353.98B | |
| Weighted average by Cap. | -0.18% | +3.83% | +32.71% | +65.19% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 23.83M 27.5M 21.93M 20.6M 38.35M 2.63B 38.97M 259M 101M 1.27B 103M 101M 4.41B | 65.45M 75.52M 60.22M 56.57M 105M 7.22B 107M 712M 277M 3.48B 283M 277M 12.1B |
| Net income | -7.68M -8.86M -7.06M -6.64M -12.36M -848M -12.55M -83.52M -32.55M -408M -33.24M -32.51M -1.42B | 12.82M 14.79M 11.8M 11.08M 20.63M 1.42B 20.96M 139M 54.35M 682M 55.51M 54.29M 2.37B |
| Net Debt | -3.3M -3.81M -3.04M -2.85M -5.31M -364M -5.4M -35.9M -13.99M -176M -14.29M -13.97M -610M | -37.5M -43.27M -34.5M -32.41M -60.34M -4.14B -61.31M -408M -159M -1.99B -162M -159M -6.93B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-08 | 5.000 € | 0.00% | 4,076 |
| 26-06-05 | 5.000 € | -0.40% | 3,319 |
| 26-06-04 | 5.020 € | -1.18% | 3,619 |
| 26-06-03 | 5.080 € | -0.78% | 5,699 |
| 26-06-02 | 5.120 € | -1.16% | 1,976 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- HYL Stock
Select your edition
All financial news and data tailored to specific country editions
